StockData
Psyence Biomedical Ltd. logo

Psyence Biomedical Ltd. (PBM) shareholders

PBMNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBMWW
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jun 22, 2026Score 0/30
$4.12−0.10 (-2.37%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0M
Shares held, 13F filers
Institutional holders
9
7 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Psyence Labs Ltd.2,643,65949.75%13D (active) amendmentOct 1, 2026
Hudson Bay Capital Management LP380,0009.98%13G (passive)Dec 31, 2024
AdvisorShares Trust258,5386.78%13G (passive)Sep 30, 2026
Harraden Circle Investors GP, LLC
Joint filing with Harraden Circle Investments, LLC (5.32%), Harraden Circle Investors GP, LP (5.32%) and 1 more
182,3235.32%13G (passive) amendmentDec 31, 2024
White Lion Capital, LLC100,0008.93%13G (passive)Dec 4, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of PBMValueChange% of portfolio
Parallel Advisors, LLC151,250–$574.75K–0.01%
AdvisorShares Investments LLC122,184–$373.88KNew0.05%
Morgan Stanley37,804–$115.68KNew0.00%
Jane Street Group, LLC30,431–$93.12KNew0.00%
XTX Topco Ltd15,094–$46.19KNew0.00%
Citadel Advisors LLC11,693–$35.78KNew0.00%
Stonehage Fleming Financial Services Holdings Ltd89–$272–0.00%
UBS Group AG60–$184New0.00%
Caitlin John, LLC35–$107New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 202690M7 / 00 / 00M0M
Q1 202620M1 / 00 / 00M0M
Q4 202510M1 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of PBMValue% of fundAs of
AdvisorShares Psychedelics ETF122,184–$373.88K0.84%Jun 30, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-6.1%
From 0M shares
Short volume, 20 days
29.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Psyence Biomedical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 9,581 shares on Aug 24, 2026 over the last 90 days.

See a number that looks wrong?